4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-045442
Director sold 9,040 shares at $1.26 ($11,390)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahadevia Ankit Director | 2023-08-28 | Sale | −9,040 | $1.26 | $11,390 | 788,792 | D |
| Open-market sales · 9,040 sh · avg $1.26 · $11,390 | |||||||
Loading xslF345X05/ownership.xml…